Stocksigma LogoStocksigma Logo

Bansisons Tea Industries Renamed Novyra Pharmachem to Reflect Pharma Focus

Bansisons Tea Industries Limited (BSE: 519353) has been renamed Novyra Pharmachem Limited, effective from 19th Jan'26

Bansisons Tea Industries Renamed Novyra Pharmachem to Reflect Pharma Focus

Bansisons Tea Industries Ltd 路 Others (Uncategorized) 路 22 Aug 2026, 7:33 pm

Bansisons Tea Industries Renamed Novyra Pharmachem to Reflect Pharma Focus Bansisons Tea Industries Limited (BSE: 519353) has been renamed Novyra Pharmachem Limited, effective from 19th Jan'26. This change reflects its strategic expansion into the pharmaceutical and life sciences sectors. The company will now focus on manufacturing and trading APIs, bulk drugs, and specialty chemicals, alongside offering contract research (CRO) and development manufacturing (CDMO) services. This move signals a significant pivot from its previous business into higher-growth pharma-related activities. The company will update its name with exchanges and depositories.

Original exchange filing (PDF)

More announcements from Bansisons Tea Industries Ltd

All Bansisons Tea Industries Ltd announcements